Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Talc vs Autologous Blood Patch Therapy for Persistent Air Leak in Secondary Spontaneous Pneumothorax
NCT06883188Phase 3Not yet recruiting
- Sponsor
- The Chinese University of Hong Kong
- Start
- Dec 2026
- Primary completion
- Nov 2029
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of autologous blood in secondary spontaneous pneumothorax (SSP), sponsored by The Chinese University of Hong Kong. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
autologous blood
03
Conditions
secondary spontaneous pneumothorax (SSP)
Beyond the preview
Go deeper on NCT06883188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06883188.